Table 3.
Age-specific prevalence rates (%) and trends in dyslipidaemia in various studies
| Lipid Parameters |
JHW-1 (n = 276) |
JHW-2 (n = 926) |
JHW-3 (n = 374) |
JHW-4 (n = 500) |
Linear curve-estimation regression coefficient. Multiple R (p value) |
| Cholesterol ≥200 mg/dl | |||||
| 20–29 | 12 (17.6) | 46 (24.6) | 11 (13.4) | 16 (17.0) | 0.034 (0.088) |
| 30–39 | 30 (29.1) | 107 (36.9) | 29 (27.1) | 36 (28.8) | |
| 40–49 | 24 (34.3) | 103 (43.3) | 41 (38.3) | 41 (27.5) | |
| 50–59 | 12 (34.3) | 107 (50.7) | 31 (39.7) | 60 (45.5) | |
| Age adjusted, 95% CI | 26.3 (20.1–32.5) | 35.1 (32.0–38.2) | 25.6 (21.1–30.0) | 26.0 (22.1–29.8) | |
| LDL cholesterol ≥130 mg/dl | |||||
| 20–29 | 9 (13.2) | 50 (26.7) | 14 (17.1) | 15 (16.0) | 0.062 (0.002) |
| 30–39 | 35 (34.0) | 111 (38.3) | 40 (37.4) | 32 (25.6) | |
| 40–49 | 21 (30.0) | 101 (42.4) | 42 (39.3) | 28 (18.8) | |
| 50–59 | 9 (25.7) | 108 (51.2) | 36 (46.2) | 52 (39.4) | |
| Age adjusted, 95% C | 24.2 (18.1–30.2) | 36.2 (33.1–39.3) | 31.0 (26.3–35.7) | 22.2 (18.6–25.8) | |
| HDL cholesterol < 40 mg/dl | |||||
| 20–29 | 36 (52.9) | 90 (48.1) | 48 (58.5) | 23 (24.5) | 0.136 (< 0.001) |
| 30–39 | 42 (40.8) | 166 (57.2) | 57 (53.3) | 51 (40.8) | |
| 40–49 | 29 (41.4) | 144 (60.5) | 58 (54.2) | 58 (38.9) | |
| 50–59 | 16 (45.7) | 103 (48.8) | 41 (52.6) | 49 (37.1) | |
| Age adjusted, 95% CI | 46.2 (40.3–52.1) | 53.3 (50.1–56.6) | 55.4 (52.2–58.6) | 33.7 (29.6–37.8) | |
| Non-HDL cholesterol ≥160 mg/dl | |||||
| 20–29 | 10 (14.7) | 41 (21.9) | 11 (13.4) | 19 (20.2) | 0.026 (0.196) |
| 30–39 | 31 (30.1) | 106 (36.5) | 32 (29.9) | 36 (28.8) | |
| 40–49 | 20 (28.6) | 100 (42.0) | 43 (40.2) | 41 (27.5) | |
| 50–59 | 8 (22.9) | 104 (49.3) | 35 (44.9) | 53 (40.2) | |
| Age adjusted, 95% CI | 23.0 (18.0–28.0) | 33.5 (30.5–36.5) | 27.4 (22.9–31.9) | 26.6 (22.7–30.5) | |
| Total/HDL ratio ≥5.0 | |||||
| 20–29 | 12 (17.6) | 67 (35.8) | 31 (37.8) | 16 (17.0) | 0.031 (0.123) |
| 30–39 | 23 (22.3) | 155 (53.4) | 62 (57.9) | 39 (31.2) | |
| 40–49 | 19 (27.1) | 135 (56.7) | 72 (67.3) | 37 (24.8) | |
| 50–59 | 10 (28.6) | 118 (55.9 | 53 (67.9) | 62 (47.0) | |
| Age adjusted, 95% CI | 22.2 (17.3–27.1) | 47.6 (44.4–50.8) | 53.2 (48.1–58.3) | 26.3 (22.4–30.2) | |
| Total/HDL ratio ≥4.0 | |||||
| 20–29 | 41 (60.3) | 119 (63.6) | 46 (56.1) | 51 (54.3) | 0.006 (0.756) |
| 30–39 | 64 (62.1) | 221 (76.2) | 82 (76.6) | 83 (66.4) | |
| 40–49 | 33 (47.1) | 191 (80.3) | 86 (80.4) | 90 (60.4) | |
| 50–59 | 21 (63.6) | 166 (78.7) | 64 (82.1) | 104 (78.8) | |
| Age adjusted, 95% CI | 58.6 (52.8–64.4) | 72.5 (69.6–75.4) | 70.1 (65.5–74.7) | 62.0 (57.8–66.3) | |
| Triglycerides ≥150 mg/dl | |||||
| 20–29 | 11 (16.2) | 38 (20.3) | 11 (13.4) | 24 (25.5) | 0.047 (0.019) |
| 30–39 | 24 (23.3) | 97 (33.4) | 17 (15.9) | 49 (39.2) | |
| 40–49 | 26 (37.1) | 71 (29.8) | 23 (21.5) | 60 (40.3) | |
| 50–59 | 15 (42.9) | 80 (37.9) | 22 (28.2) | 52 (39.4) | |
| Age adjusted, 95% CI | 25.7 (19.5–31.8) | 28.2 (25.3–31.1) | 17.5 (13.7–21.4) | 34.2 (30.0–38.3) | |
| Remnant cholesterol ≥25 mg/d | |||||
| 20–29 | 20 (29.4) | 55 (29.4) | 18 (22.0) | 48 (51.1) | 0.143 (< 0.001) |
| 30–39 | 38 (36.9) | 135 (46.6) | 30 (28.0) | 85 (68.01) | |
| 40–49 | 40 (57.1) | 105 (44.1) | 41 (38.3) | 97 (65.1) | |
| 50–59 | 19 (54.3) | 112 (53.1) | 37 (47.4) | 87 (65.9) | |
| Age adjusted, 95% CI | 40.1 (34.3–45.9) | 40.3 (37.1–43.4) | 30.1 (25.4–34.7) | 60.6 (56.4–64.9) |